GNPX 2017 Annual Report

F-4 Genprex, Inc. Statements of Operations Year Ended December 31, 2017 2016 Revenues $ — $ — Cost and expenses: Depreciation 3,242 862 Research and development 289,934 354,883 General and administrative 3,019,171 3,776,414 Total costs and expenses 3,312,347 4,132,159 Operating loss (3,312,347) (4,132,159) Other income (expense): Interest income 80 — Interest expense (1,890) — Other income (expense) (1,810) — Net loss $ (3,314,157) $ (4,132,159) Net loss per share (0.29) (0.38) Weighted average number of shares Weighted average number of common shares (basic and diluted) 11,500,032 10,834,685 See accompanying notes to the financial statements